These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche. Siklar Z; Oçal G; Adiyaman P; Ergur A; Berberoğlu M J Pediatr Endocrinol Metab; 2007 Apr; 20(4):475-81. PubMed ID: 17550211 [TBL] [Abstract][Full Text] [Related]
3. Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. Ibáñez L; de Zegher F; Potau N J Endocrinol Invest; 1998 Oct; 21(9):558-66. PubMed ID: 9856410 [TBL] [Abstract][Full Text] [Related]
4. [Polycystic ovary syndrome in pubertal period: clinical, biological, metabolic and genetic polymorphism]. Trimèche S; Thuan Dit Dieudonne JF; Jeandel C; Paris F; Simoni-Brum I; Orio F; Sultan C Gynecol Obstet Fertil; 2004 Jan; 32(1):3-17. PubMed ID: 14736594 [TBL] [Abstract][Full Text] [Related]
5. Maternal polycystic ovarian syndrome and pubertal development in daughters and sons: a population-based cohort study. Lunddorf LLH; Arendt LH; Ernst A; Brix N; Knudsen UB; Olsen J; Ramlau-Hansen CH Hum Reprod; 2022 Oct; 37(11):2623-2634. PubMed ID: 36099165 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome. Glueck CJ; Morrison JA; Wang P J Pediatr Endocrinol Metab; 2008 Oct; 21(10):973-84. PubMed ID: 19209619 [TBL] [Abstract][Full Text] [Related]
8. Adolescent polycystic ovary syndrome. Connor EL Adolesc Med State Art Rev; 2012 Apr; 23(1):164-77, xii. PubMed ID: 22764561 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Polycystic Ovarian Syndrome in Girls with a History of Idiopathic Central Precocious Puberty. Arcari AJ; Freire AV; Ballerini MG; Escobar ME; Díaz Marsiglia YM; Bergadá I; Ropelato MG; Gryngarten MG Horm Res Paediatr; 2024; 97(2):134-139. PubMed ID: 37552972 [TBL] [Abstract][Full Text] [Related]
10. Obesity and the pubertal transition in girls and boys. Burt Solorzano CM; McCartney CR Reproduction; 2010 Sep; 140(3):399-410. PubMed ID: 20802107 [TBL] [Abstract][Full Text] [Related]
11. Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome. Banerjee S; Raghavan S; Wasserman EJ; Linder BL; Saenger P; DiMartino-Nardi J Pediatrics; 1998 Sep; 102(3):E36. PubMed ID: 9724684 [TBL] [Abstract][Full Text] [Related]
12. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ; Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855 [TBL] [Abstract][Full Text] [Related]
13. Unfavorable Hormonal and Psychologic Profile in Adult Women with a History of Premature Adrenarche and Pubarche, Compared to Women with Polycystic Ovary Syndrome. Livadas S; Bothou C; Kanaka-Gantenbein C; Chiotis D; Angelopoulos N; Macut D; Chrousos GP Horm Metab Res; 2020 Mar; 52(3):179-185. PubMed ID: 32074632 [TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect. Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F Clin Endocrinol (Oxf); 2001 Nov; 55(5):667-72. PubMed ID: 11894979 [TBL] [Abstract][Full Text] [Related]
15. Premature adrenarche--normal variant or forerunner of adult disease? Ibáñez L; Dimartino-Nardi J; Potau N; Saenger P Endocr Rev; 2000 Dec; 21(6):671-96. PubMed ID: 11133068 [TBL] [Abstract][Full Text] [Related]
17. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495 [TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria? Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788 [TBL] [Abstract][Full Text] [Related]
19. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F J Clin Endocrinol Metab; 2011 Aug; 96(8):E1262-7. PubMed ID: 21632811 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. Rosenfield RL; Ghai K; Ehrmann DA; Barnes RB J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1285-9. PubMed ID: 11117671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]